Cost-effectiveness of 5-ASA Therapy Plus Biologics or Tofacitinib for Ulcerative Colitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The American Journal of Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis
Am. J. Gastroenterol 2021 Jan 01;116(1)125-133, SR Shaffer, E Huang, S Patel, DT RubinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.